Loading chat...
NY A02415
Bill
Status
1/20/2017
Primary Sponsor
Amy Paulin
Click for details
AI Summary
-
Mandates health insurance policies to cover non-experimental infertility treatments, including diagnostic procedures and FDA-approved prescription drugs used for diagnosis and treatment of infertility.
-
Specifies covered diagnostic and treatment procedures including hysterosalpingogram, hysteroscopy, endometrial biopsy, laparoscopy, in-vitro fertilization, intrauterine insemination, embryo transfer, donor eggs, and donor sperm.
-
Limits infertility coverage to individuals aged 21-44 years who have maintained continuous policy coverage for at least 12 months, with a lifetime benefit cap of $100,000 for advanced fertility procedures.
-
Excludes coverage for reversal of elective sterilizations, sex change procedures, cloning, and experimental procedures as determined by clinical guidelines from the American College of Obstetricians and Gynecologists and American Society for Reproductive Medicine.
-
Requires the superintendent of financial services, in consultation with the health commissioner, to establish regulations defining infertility, identifying experimental procedures, and setting standards for provider qualifications and medical candidate determination.
Legislative Description
Mandates insurance companies to provide coverage for non-experimental infertility treatments; provides that coverage shall not be required to include the diagnosis and treatment of infertility in connection with the reversal of elective sterilizations, sex change procedures, cloning or medical or surgical services or procedures that are deemed to be experimental; provides the superintendent of financial services in consultation with the commissioner of the department of health shall determine infertility for purposes of coverage.
Last Action
enacting clause stricken
6/21/2018